A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine
| Autor: | Undevia, S.D., Kindler, H.L. *, Janisch, L., Olson, S.C., Schilsky, R.L., Vogelzang, N.J., Kimmel, K.A., Macek, T.A., Ratain, M.J. |
|---|---|
| Zdroj: | In Annals of Oncology November 2004 15(11):1705-1711 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|